Cardiome Pharma Corp. (CRME) Sank To An 8-Month Low On FDA News

The FDA has advised Cardiome Pharma Corp. (CRME) that the data package proposed by the company would not be sufficient to support a resubmission of the BRINAVESS New Drug Application.

from RTT - Before the Bell http://ift.tt/2inGwaS
via IFTTT